A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller DH; Khan OA; Sheremata WA; Blumhardt LD; Rice GP; Libonati MA; Willmer-Hulme AJ; Dalton CM; Miszkiel KA; O'Connor PW; The New England Journal Of Medicine, 2003, vol. 348, issue 1, p 15, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation